Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Not Confirmed
Not Confirmed
01-02 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Industry Trade Show
Not Confirmed
01-02 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
25 Sep 2024
// ACCESSWIRE
https://www.accesswire.com/923249/prevail-partners-and-prevail-infoworks-enter-into-strategic-investment-and-clinical-alliance-with-kairos-pharma-ltd
17 Apr 2024
// James Waldron FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/lillys-prevail-walks-away-gene-editing-collab-precision
18 Jul 2023
// PRESS RELEASE
https://investor.sangamo.com/news-releases/news-release-details/sangamo-therapeutics-announces-research-evaluation-and-option
07 Jul 2023
// Gabrielle Masson FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/lillys-prevail-revises-26b-biobucks-deal-precision-taking-more-preclinical-responsibilities
17 May 2023
// Gabrielle Masson FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/lillys-prevail-inks-15b-pact-doudnas-scribe-crispr-tech
05 Jan 2023
// Delilah Alvarado BIOPHARMADIVE
https://www.biopharmadive.com/news/capsida-prevail-lilly-aav-gene-therapy-partner/639591/
ABOUT THIS PAGE